Papenhausen Peter R, Kelly Carla A, Harris Samuel, Caldwell Samantha, Schwartz Stuart, Penton Andrea
Cytogenetics Department, Laboratory Corporation of America, Research Triangle Park, NC, 27709, USA.
Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.
Mol Cytogenet. 2021 Jul 20;14(1):38. doi: 10.1186/s13039-021-00555-0.
Whole chromosome uniparental disomy (UPD) has been well documented with mechanisms largely understood. However, the etiology of segmental limited UPD (segUPD) is not as clear. In a 10-year period of confirming (> 300) cases of whole chromosome UPD, we identified 86 segmental cases in both prenatal and postnatal samples. Thirty-two of these cases showed mosaic segmental UPD at 11p due to somatic selection associated with Beckwith-Wiedemann syndrome. This study focuses on apparent mechanisms associated with the remaining cases, many of which appear to represent corrections of genomic imbalance such as deletions and derivative chromosomes. In some cases, segmental UPD was associated with the generation of additional genomic imbalance while in others it apparently resulted in restoration of euploidy. Multiple tests utilizing noninvasive prenatal testing (NIPT), chorionic villus sampling (CVS) and amniotic fluid samples from the same pregnancy revealed temporal evidence of correction and a "hotspot" at 1p. Although in many cases the genomic imbalance was dosage "repaired" in the analyzed tissue, clinical effects could be sustained due to early developmental effects of the original imbalance or due to its continued existence in other tissues. In addition, if correction did not occur in the gametes there would be recurrence risks for the offspring of those individuals. Familial microarray allele patterns are presented that differentiate lack of gamete correction from somatic derived gonadal mosaicism. These results suggest that the incidence of segUPD mediated correction is underestimated and may explain the etiology of some clinical phenotypes which are undetected by routine microarray analysis and many exome sequencing studies.
全染色体单亲二体性(UPD)已有充分记录,其机制也基本为人所理解。然而,节段性局限性UPD(segUPD)的病因尚不清楚。在长达10年的全染色体UPD确诊(>300例)病例研究中,我们在产前和产后样本中识别出86例节段性病例。其中32例因与贝克威思-维德曼综合征相关的体细胞选择而在11p处表现为嵌合节段性UPD。本研究聚焦于与其余病例相关的明显机制,其中许多似乎代表了基因组失衡(如缺失和衍生染色体)的纠正。在某些情况下,节段性UPD与额外基因组失衡的产生有关,而在其他情况下,它显然导致了整倍体的恢复。利用同一妊娠的无创产前检测(NIPT)、绒毛取样(CVS)和羊水样本进行的多项检测揭示了纠正的时间证据以及1p处的一个“热点”。尽管在许多情况下,分析组织中的基因组失衡在剂量上得到了“修复”,但由于原始失衡的早期发育影响或其在其他组织中的持续存在,临床影响可能会持续存在。此外,如果配子中未发生纠正,这些个体的后代将存在复发风险。文中展示了家族性微阵列等位基因模式,以区分配子未纠正与体细胞来源的性腺嵌合现象。这些结果表明,segUPD介导的纠正发生率被低估了,这可能解释了一些临床表型的病因,而这些表型在常规微阵列分析和许多外显子组测序研究中未被检测到。
Mol Cytogenet. 2021-7-20
J Med Genet. 2008-9
Ultrasound Obstet Gynecol. 2008-1
Prenat Diagn. 1996-4
J Med Genet. 1994-10
Genes (Basel). 2024-11-30
Eur J Hum Genet. 2025-1
Genet Med. 2021-6
Am J Med Genet A. 2020-11